Skip to content

Research on the construction and effect evaluation of the hospital-wide blood glucose management model with the participation of clinical pharmacists

Research on the construction and effect evaluation of the hospital-wide blood glucose management model with the participation of clinical pharmacists

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068164
Enrollment
Unknown
Registered
2023-02-09
Start date
2023-02-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Intervention:whole-hospital blood glucose management
control group:General consultation

Sponsors

Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?All are non-endocrinology inpatients; ?Diabetes course > 6 months; ?Blood glucose level after admission> 7.8mmol/L; ?Age= 18 years old; ?The admitted patients have a clear clinical path and treatment plan for their diseases; ?Voluntarily undergo testing and sign informed consent; ?Be able to communicate well with researchers and follow the requirements of the entire trial; ?Be able to understand the interpretation of relevant scales of medical staff and cooperate with the completion of relevant scale evaluation.

Exclusion criteria

Exclusion criteria: ? Do not meet the inclusion criteria; ? Patients with long-term combined use of drugs affecting blood glucose fluctuation; ? Patients with long-term use of enteral and parenteral nutrition preparations; ? Patients with weak physique who cannot strengthen management; ? Patients unwilling to conduct blood glucose monitoring; ? Incomplete basic information and inspection data; ? Senile dementia, cerebral atrophy, acute cerebrovascular disease or sequela, cognitive impairment; ? Local or systemic bacterial infection can not be effectively controlled in the acute stage; ? Patients with shock and critical illness who can not cooperate with the operation and evaluate the effect; ? Other circumstances that the researcher deems inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Blood glucose compliance rate;

Secondary

MeasureTime frame
Length of stay;Hospitalization costs;

Countries

China

Contacts

Public ContactCheng Ji

Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School

getcct@sina.com15996232038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026